33
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
October 1, 2025
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Obtenir le Premium
Close
Create a timeline
Public timelines
Library
FAQ
About & Feedback
Un accord
Confidentialité
Bibliothèque
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
Share
Ocular Therapeutix
Category:
Autre
mise à jour avec succès:
5 févr. 2020
0
0
269
Auteurs
Created by
Nathan
Attachments
Comments
Les événements
Founded
Series A $1.17M (Undisclosed Investors)
Series B $6.09 M Pinnacle Ventures SV Health Investors Versant Venture Management
Series C $21.53 M Polaris Partners SV Health Investors Versant Venture Management
Series D $23.79 M Ascension Ventures Baxter Ventures Polaris Partners Sparta Capital Partners SV Health Investors Versant Venture Management
Debt $20 M Flexpoint Ford Silicon Valley Bank
IPO $65 M
Stock Drops 30%
Dextenza Approved
Périodes
Phase 2 Dextenza Post-Surgical Inflammation and Pain
Phase 3 Dextenza Post-Surgical Inflammation and Pain
About & Feedback
Un accord
Confidentialité
Bibliothèque
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments